Compare CVS Health Corp (CVS) vs Google Inc (GOOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Google Inc — how do they compare? CVS Health Corp trades at $93.7 (market cap $122.36B), while Google Inc trades at $344.83 (market cap $4.36T). The key difference: Google Inc is far larger — about 35.6× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| CVS | GOOG | |
|---|---|---|
Market Cap | $122.36B | $4.36T |
Sector | Health | Technology |
52-Week High | $110.60 | $399.06 |
52-Week Low | $65.51 | $200.19 |
Enterprise Value | $184.71B | $4.25T |
Dividend Yield | 2.78% | 0.25% |
Volume | — | 1,511,127 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Alphabet (GOOG) trades at $353.47, down 0.88% today, with a bullish technical outlook supported by moving averages and strong support at $352. The company shows robust fundamentals, with 2025 revenue of $402.84B and net income of $132.17B, alongside consecutive earnings beats in recent quarters. Recent news highlights aggressive AI investments and cloud growth, while analyst sentiment remains overwhelmingly positive.
The outlook for GOOG is favorable, driven by AI expansion and cloud revenue growth, with a consensus price target of $431.67 implying significant upside. Risks include high capital expenditures, competitive pressures, and regulatory scrutiny, but strong cash flow and profitability metrics support a bullish investment case for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →
